Literature DB >> 19520913

LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.

Noam Zelcer1, Cynthia Hong, Rima Boyadjian, Peter Tontonoz.   

Abstract

Cellular cholesterol levels reflect a balance between uptake, efflux, and endogenous synthesis. Here we show that the sterol-responsive nuclear liver X receptor (LXR) helps maintain cholesterol homeostasis, not only through promotion of cholesterol efflux but also through suppression of low-density lipoprotein (LDL) uptake. LXR inhibits the LDL receptor (LDLR) pathway through transcriptional induction of Idol (inducible degrader of the LDLR), an E3 ubiquitin ligase that triggers ubiquitination of the LDLR on its cytoplasmic domain, thereby targeting it for degradation. LXR ligand reduces, whereas LXR knockout increases, LDLR protein levels in vivo in a tissue-selective manner. Idol knockdown in hepatocytes increases LDLR protein levels and promotes LDL uptake. Conversely, adenovirus-mediated expression of Idol in mouse liver promotes LDLR degradation and elevates plasma LDL levels. The LXR-Idol-LDLR axis defines a complementary pathway to sterol response element-binding proteins for sterol regulation of cholesterol uptake.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520913      PMCID: PMC2777523          DOI: 10.1126/science.1168974

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  Identification of macrophage liver X receptors as inhibitors of atherosclerosis.

Authors:  Rajendra K Tangirala; Eric D Bischoff; Sean B Joseph; Brandee L Wagner; Robert Walczak; Bryan A Laffitte; Chris L Daige; Diane Thomas; Richard A Heyman; David J Mangelsdorf; Xuping Wang; Aldons J Lusis; Peter Tontonoz; Ira G Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

Review 2.  Liver X receptors as integrators of metabolic and inflammatory signaling.

Authors:  Noam Zelcer; Peter Tontonoz
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

3.  Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.

Authors:  Jonathan Cohen; Alexander Pertsemlidis; Ingrid K Kotowski; Randall Graham; Christine Kim Garcia; Helen H Hobbs
Journal:  Nat Genet       Date:  2005-01-16       Impact factor: 38.330

4.  Synthetic LXR ligand inhibits the development of atherosclerosis in mice.

Authors:  Sean B Joseph; Elaine McKilligin; Liming Pei; Michael A Watson; Alan R Collins; Bryan A Laffitte; Mingyi Chen; Grace Noh; Joanne Goodman; Graham N Hagger; Jonathan Tran; Tim K Tippin; Xuping Wang; Aldons J Lusis; Willa A Hsueh; Ronald E Law; Jon L Collins; Timothy M Willson; Peter Tontonoz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

5.  Post-transcriptional regulation of retroviral vector-transduced low density lipoprotein receptor activity.

Authors:  M F Sharkey; A Miyanohara; R L Elam; T Friedmann; J L Witztum
Journal:  J Lipid Res       Date:  1990-12       Impact factor: 5.922

Review 6.  Molecular mechanisms of autosomal recessive hypercholesterolemia.

Authors:  Jonathan C Cohen; Marek Kimmel; Andrzej Polanski; Helen H Hobbs
Journal:  Curr Opin Lipidol       Date:  2003-04       Impact factor: 4.776

7.  Functional activities and cellular localization of the ezrin, radixin, moesin (ERM) and RING zinc finger domains in MIR.

Authors:  Beat C Bornhauser; Cecilia Johansson; Dan Lindholm
Journal:  FEBS Lett       Date:  2003-10-09       Impact factor: 4.124

8.  Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.

Authors:  Da-Wei Zhang; Thomas A Lagace; Rita Garuti; Zhenze Zhao; Meghan McDonald; Jay D Horton; Jonathan C Cohen; Helen H Hobbs
Journal:  J Biol Chem       Date:  2007-04-23       Impact factor: 5.157

9.  Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs.

Authors:  Christopher M Adams; Julian Reitz; Jef K De Brabander; Jamison D Feramisco; Lu Li; Michael S Brown; Joseph L Goldstein
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

10.  The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.

Authors:  Nabil G Seidah; Suzanne Benjannet; Louise Wickham; Jadwiga Marcinkiewicz; Stephanie Belanger Jasmin; Stefano Stifani; Ajoy Basak; Annik Prat; Michel Chretien
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more
  322 in total

1.  PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain.

Authors:  Mali Liu; Guoxin Wu; Jennifer Baysarowich; Michael Kavana; George H Addona; Kathleen K Bierilo; John S Mudgett; Guillaume Pavlovic; Ayesha Sitlani; John J Renger; Brian K Hubbard; Timothy S Fisher; Celina V Zerbinatti
Journal:  J Lipid Res       Date:  2010-05-07       Impact factor: 5.922

2.  Mitotic down-regulation of p190RhoGAP is required for the successful completion of cytokinesis.

Authors:  Sergio A Sánchez Manchinelly; Joyce Agati Miller; Ling Su; Tsuyoshi Miyake; Lisa Palmer; Masahito Mikawa; Sarah J Parsons
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

3.  Heritability of submaximal exercise heart rate response to exercise training is accounted for by nine SNPs.

Authors:  Tuomo Rankinen; Yun Ju Sung; Mark A Sarzynski; Treva K Rice; D C Rao; Claude Bouchard
Journal:  J Appl Physiol (1985)       Date:  2011-12-15

4.  Dynamical probing of allosteric control in nuclear receptors.

Authors:  Mark A Cunningham
Journal:  J Mol Model       Date:  2012-01-06       Impact factor: 1.810

Review 5.  Liver X receptors, atherosclerosis and inflammation.

Authors:  Daryn R Michael; Tim G Ashlin; Melanie L Buckley; Dipak P Ramji
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 6.  Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.

Authors:  Monte S Willis; W H Davin Townley-Tilson; Eunice Y Kang; Jonathon W Homeister; Cam Patterson
Journal:  Circ Res       Date:  2010-02-19       Impact factor: 17.367

7.  Meeting report: nuclear receptors: transcription factors and drug targets connecting basic research with translational medicine.

Authors:  Jan Tuckermann; William Bourguet; Susanne Mandrup
Journal:  Mol Endocrinol       Date:  2010-06-02

8.  Synthetic LXR agonist suppresses endogenous cholesterol biosynthesis and efficiently lowers plasma cholesterol.

Authors:  Thomas Pfeifer; Marlene Buchebner; Prakash G Chandak; Jay Patankar; Adelheid Kratzer; Sascha Obrowsky; Gerald N Rechberger; Rajendra S Kadam; Uday B Kompella; Gerhard M Kostner; Dagmar Kratky; Sanja Levak-Frank
Journal:  Curr Pharm Biotechnol       Date:  2011-02-01       Impact factor: 2.837

Review 9.  A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport.

Authors:  Ryan-E Temel; J-Mark Brown
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

10.  IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor.

Authors:  Elena Scotti; Martino Calamai; Chris N Goulbourne; Li Zhang; Cynthia Hong; Ron R Lin; Jinkuk Choi; Paul F Pilch; Loren G Fong; Peng Zou; Alice Y Ting; Francesco S Pavone; Stephen G Young; Peter Tontonoz
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.